REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot159010.32687/1561-5936-2023-27-1-26-32Original ArticleDetermination of management tactics for patients with cervical diseases based on the calculation of the prognostic indexAminodovaIsabella P.001VasilevMichail D.002MakarovaEkaterina V.003BeneslavskayaOlga A.004The Medical Center «Belaya Roza» Ivanovo, Russian FederationN. A. Semashko National Research Institute of Public Health, Moscow, Russian Federation151220231263209102025Copyright © 2023,2023Today in cervical cancer diagnostics special attention is paid to the identification of a cohort of women with relatively high risk for the disease development among general population. The objective of the study was development and evaluation of possible prognostic criteria for treatment tactics determination in women with cervical diseases. Based on the data obtained by the method of intensive indicators normalization, a scale for risk prediction of cervical cancer development was formed and its effectiveness was evaluated. Our analysis demonstrated feasibility of introducing into clinical practice a method for cervical cancer developing risk assessment with a four-degree prognostic scale based on a comprehensive examination. This research could contribute to an evidence-based medical decision-making in management of patients with abnormal primary examination results; help in shortening the diagnostic interval for cervical diseases verification of; as such as increase the effectiveness of cervical cancer secondary prevention.diseases of the cervix uteri, cervical intraepithelial neoplasia, a comprehensive examination, prognosisзаболевания шейки матки, дисплазия шейки матки комплексное обследование, прогнозированиеCervical cancer. Eds. I. V. Berlev, A. F. Urmancheeva. St. Petersburg; 2018. (In Russ.)Alexandrova L. M., Gretsova O. P., Petrova G. V. et al. Preventable cervical cancer mortality as indicator of disease prevention effectiveness. The Russian Journal of Preventive Medicine. 2020; 23(3): 56—63. (In Russ.) doi: 10.17116/profmed20202303156Malignant neoplasms in Russia in 2018 (morbidity and mortality). Eds. A. D. Kaprin, V. V. Starinsky, G. M. Petrova. Moscow; 2019. (In Russ.)Rogovskaya S. I., Shabalova I. P., Ulumbekova G. E. et al. The cervical cancer prevention in Russia. Healthcare Management: News. Views. Education. Bulletin of VSHOUZ. 2021; 7(4): 16—31. (In Russ.) doi: 10.33029/2411-8621-2021-7-4-16-31Fattakhov T. A., Mironova A. A., Pyankova A. I., Shahzadova A. O. Cancer mortality in Russia for the period of 1965—2019: main structural changes and trends. Siberian Journal of Oncology. 2021; 20(4): 5—20. (In Russ.) doi: 10.21294/1814-4861-2021-20-4-5-20Budaev B. S., Banzarova L. P., Bogdanova O. G., Tarmaeva I. Yu. Analysis of malignant neoplasms mortality rate of the population at the regional level. Pacific Medical Journal. 2021; (3): 71—76. (In Russ.) doi: 10.34215/1609-1175-2021-3-71-76Alexandrova L. M., Mamontov A. S., Kaprin A. D. The impact of the COVID-19 pandemic on the diagnosis of malignant neoplasms during preventive medical examinations. P. A. Herzen Journal of Oncology. 2021; 10(6): 77—82. (In Russ.) doi: 10.17116/onkolog20211006177Merabishvili V. M. Medium-term prognosis of cancer mortality among the population of Russia. Siberian Journal of Oncology. 2019; 18(4): 5—12. (In Russ.) doi: 10.21294/1814-4861-2019-18-4-5-12Bayramova G. R., Fayzullin L. Z., Korolkova A. I. et al. Cervical cancer screening: what is new in global practice? Obstetrics and Gynecology. 2016; (7): 17—21. (In Russ.) doi: 10.18565/aig.2016.7.17—21Bebneva T. N. We know how, but we do not use enough. Status Praesens. Gynecology, obstetrics, barren marriage. 2017; (3): 113—120. (In Russ.)Belokrinitskaya T. E., Frolova N. I., Tarbaeva D. A. et al. Confounding factors for papillomavirus infection and cervical dysplasia in young women. Doctor.ru. 2015; (14): 6—11. (In Russ.)Burmenskaya O. V., Nazarova N. M., Prilepskaya V. N. et al. Prediction of the risk and progression of cervical intraepithelial neoplasias associated with papillomavirus infection. Obstetrics and Gynecology. 2016; (2): 92—98. (In Russ.) doi: 10.18565/aig.2016.2.92—98Shmakova N. A., Chistyakova G. N., Kononova I. N. et al. High oncogenic risk of cervical intraepithelial neoplasia and cervical cancer: the urgency of the problem, the search for prospects (literature review). Russian Journal of Human Reproduction. 2021; 27(1): 33—38. (In Russ.) doi: 10.17116/repro20212701133Mikhalkina E. V., Skachkova L. S., Kit O. I., Fomenko Yu. A. Socioeconomic predictors of cancer. Journal of Institutional Studies. 2020; 12(3): 122—141. (In Russ.) doi: 10.17835/2076-6297.2020.12.3.122—141Khoroshevskaya I. V., Bel'skikh O. L. Risk factors for ovarian cancer. Youth Innovation Bulletin. 2019; 8(2): 159—160. (In Russ.)Petrov Yu. A., Blesmanovich A. E., Bagnovskaya A. G. From background processes to cervical cancer: causes, diagnosis and prevention. Chief Physician of the South of Russia. 2020; (4): 36—39. (In Russ.)Efimova N. V., Rukavishnikov V. S., Myl’Nikova I. V. Comprehensive epidemiological analysis of the risk of malignant neoplasms: experience of the implementation. Hygiene and Sanitation. 2021; 100(11): 1317—1322. (In Russ.) doi: 10.47470/0016-9900-2021-100-11-1317-1322Firichenko S. V., Manukhin I. B., Rogovskaya S. I., Manukhina E. I. Pitfalls in cervical screening. Doctor.ru. 2018; (2): 26—34. (In Russ.)Breast medicine and gynecological diseases. Ed. V. E. Radzinsky. Moscow; 2017. (In Russ.)